You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Exploring a new direction in targeted cancer therapy through hyperbaric oxygen therapy combined with biomedical engineering techniques
- 2. The role and mechanisms of exosome microRNA in regulating metastasis within the tumor microenvironment of prostate cancer
- 3. Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a potential value of up to $1.35bn plus royalties
- 4. What surviving cancer outliers can teach us: The tech behind a new paradigm in oncology
- 5. Nanomaterials targeting cancer stem cells to overcome drug resistance and tumor recurrence
- 6. Food-derived compounds targeting ferroptosis for cancer therapy: from effects to mechanisms
- 7. [Latest] Global Neoantigen Cancer Vaccine Market Size/Share Worth USD 1.98 Billion by 2034 at a 15.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
- 8. Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project
- 9. Pancreatic cancer vaccines eliminate disease in preclinical trials
- 10. Your favorite alcoholic beverage could be linked to deadly form of cancer, study finds
Last updated at 16:26 GMT
Hot News Makers
Health/Pharma Companies
-
429679.13
-
106877.31
-
94543.72
-
50554.24
-
26284.89
-
16448.58
-
11614.65
-
11209.38
-
9646.87
-
7212.44
Drugs, Treatments, Trials
-
51878.38
-
10437.50
-
10358.02
-
7629.10
-
7521.58
-
6165.29
-
5607.79
-
4872.22
-
4571.86
-
4542.25
Last updated at 16:10 GMT
